ToolsConductScience tool
mg/kg → µL/minFree in-browser calculator

Rodent Infusion Dosing Planner.

Enter animal weight, drug concentration, and target dose. Get pump rate, total volume, drug requirements with 20% overage, and blood volume safety check. Supports dose ramp scheduling.

PrivateData stays in your browser
LiveNo sign-up required
Open methodFormula shown on this page
CitableMethods and citation included

Calculator

Results update in place

Try it out

Load example infusion dosing data to see the full workflow

Animal

Drug

Infusion

When to use

  • Convert a mg/kg/hr drug dose to a syringe pump flow rate (uL/min) based on animal weight and drug concentration
  • Plan a multi-animal infusion study with total volume requirements, syringe selection, and built-in overage calculation
  • Verify that your infusion protocol stays within published blood volume safety limits for mice or rats
  • Design a dose escalation (ramp) protocol with step-wise flow rates and cumulative volume tracking
  • Compare infusion parameters across different drug concentrations or animal weight ranges
  • Generate a dosing summary table for IACUC protocol submissions or study reports

Do not use for

  • Oral gavage or dietary dosing calculations — these depend on feed consumption rates, GI absorption kinetics, and formulation factors not addressed by IV infusion models
  • Intraperitoneal (IP) or subcutaneous (SC) bolus injection volumes — bolus injections follow different volume limit guidelines and do not involve continuous pump delivery
  • Human clinical infusion dosing — human dosing requires allometric scaling, BSA-based conversions, and clinical safety monitoring beyond the scope of this preclinical tool

Account for dead volume in tubing and catheter

The volume contained in the infusion line from the syringe to the catheter tip (dead volume) must be filled with drug solution before the animal begins receiving the dose. For a typical rodent tether-swivel setup with 30 cm of PE-50 tubing, the dead volume is approximately 15-20 uL. At very low flow rates (less than 1 uL/min), this dead volume can delay drug delivery by 15-20 minutes. Pre-fill the entire line with drug solution before connecting to the animal, or account for the lag time in your PK sampling schedule.

Respect the 4 mL/kg/hr blood volume rule

The most common safety error in rodent infusion studies is exceeding the recommended infusion volume rate. For a 25 g mouse, 4 mL/kg/hr translates to only 100 uL/hr or 1.67 uL/min. If your drug has limited solubility and requires a dilute solution, you may hit this volume ceiling well before reaching the target pharmacological dose. Always calculate the volume rate before finalizing the drug concentration, and increase concentration (not rate) whenever possible.

Drug concentration limits and precipitation

Maximizing drug concentration to stay within volume limits can push the solution toward its solubility limit, risking precipitation in the syringe, tubing, or at the catheter tip — especially as the solution equilibrates to body temperature (37 degrees C). Test solubility at 37 degrees C, not just room temperature. Inspect the syringe and tubing for particulates periodically during long infusions. Add a 0.22 um in-line filter downstream of the pump if the drug formulation tolerates it.

Vehicle toxicity at high infusion volumes

Even well-tolerated vehicles become toxic at high cumulative volumes or when co-solvents are present. DMSO should not exceed 1% v/v in IV infusions; PEG-400 should stay below 40% of the vehicle; ethanol below 10%. Cyclodextrin-based vehicles (e.g., Captisol) are generally better tolerated but still have upper concentration limits (typically 20-30% w/v). Calculate the total co-solvent dose delivered over the infusion duration and compare against published IV toxicity thresholds for each vehicle component.

Dose ramp titration: allow time to reach steady state

When using a dose escalation protocol, each step must be held long enough for plasma concentrations to approach steady state (approximately 4-5 elimination half-lives) before escalating. If steps are too short, the measured response reflects a mixture of the current and previous doses, confounding dose-response analysis. For drugs with half-lives longer than 1 hour, within-subject escalation designs may require impractically long study durations — consider a parallel-group design with fixed doses instead.

1

Method

Flow rate is computed as: Q (uL/min) = [Dose (mg/kg/hr) x Body Weight (kg)] / [Concentration (mg/mL) x 60] x 1000. Blood volume safety is verified against published species-specific blood volume tables (72 mL/kg for mice, 64 mL/kg for rats) with configurable maximum infusion rate thresholds (default 4 mL/kg/hr for conscious animals). Total required volume is calculated as: V = Q x Duration x N_animals x (1 + Overage%), where the default overage is 20% to account for priming, dead volume, and syringe residual. Dose escalation ramps compute per-step flow rates as proportional fractions of the target rate with cumulative volume tracking. All computation is performed client-side — no data leaves your browser.

2

Published

Published 2026-04-05. Calculations support planning and documentation; verify procurement decisions against manufacturer specifications or institutional SOPs.

3

How to cite

How to Cite

ConductScience Rodent Infusion Dosing Planner. ConductScience, Inc. 2026. Available at: https://conductscience.com/tools/rodent-infusion-rate-calculator

This tool performs mathematical calculations based on published preclinical infusion dosing guidelines and species-specific blood volume data. It does not account for drug-specific pharmacokinetics, protein binding, metabolism, or individual animal variation. Infusion protocols should be reviewed by a veterinarian and approved by your institutional animal care and use committee (IACUC) before implementation.

Continuous Infusion in Preclinical Research

Continuous intravenous infusion is a cornerstone delivery method in preclinical pharmacology, enabling researchers to maintain stable plasma drug concentrations over extended periods without the peak-trough fluctuations inherent to bolus dosing. This is particularly important for compounds with short elimination half-lives, narrow therapeutic windows, or concentration-dependent pharmacodynamic effects where sustained exposure above a minimum effective concentration is required. In rodent studies, continuous infusion is delivered via surgically implanted jugular vein catheters connected to an external syringe pump through a tether and swivel system that allows the animal to move freely in its home cage. The infusion rate must be precisely calculated from the desired dose (mg/kg/hr), the animal's body weight, and the drug concentration in solution. Errors in this calculation — such as confusing mg/kg/hr with mg/kg/day, using the wrong body weight, or miscalculating the drug concentration after dilution — are among the most common and consequential mistakes in preclinical infusion studies, potentially leading to sub-therapeutic exposure, toxicity, or animal welfare concerns. Careful dose-to-rate conversion, verified against blood volume safety limits, is essential for every infusion study. Modern syringe pumps offer programmable rate profiles including constant rate, ramping, pulsed, and bolus-plus-maintenance modes, but the accuracy of the delivered dose ultimately depends on the accuracy of the rate calculation entered by the researcher.

Blood Volume and Safety Limits

The maximum volume that can be safely infused into a rodent is constrained by the animal's total circulating blood volume and its capacity to compensate for volume loading. Published blood volume estimates are approximately 72 mL/kg for mice and 64 mL/kg for rats, with strain-specific variation of roughly 5-10%. Regulatory and institutional guidelines, including those from the European Medicines Agency (EMA), the UK Home Office, and the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), recommend that continuous IV infusion rates should not exceed 4 mL/kg/hr in conscious rodents for prolonged infusions (greater than 24 hours). For shorter infusion durations (less than 4 hours), rates up to 5 mL/kg/hr are generally acceptable in conscious animals, and up to 10 mL/kg/hr under anesthesia where cardiovascular monitoring is available. Exceeding these limits can cause hemodilution (reducing hematocrit and oxygen-carrying capacity), hypervolemia (increasing cardiac preload and venous pressure), pulmonary edema, and electrolyte imbalances. The practical implication is that the drug solution must be sufficiently concentrated to deliver the required dose within the allowable volume rate. When the target dose demands a flow rate that approaches blood volume limits, the drug concentration should be increased (if solubility permits) rather than the infusion rate. This tool automatically flags protocols where the calculated infusion volume rate exceeds recommended thresholds based on the animal species and body weight entered.

Dose Escalation Protocols

Dose escalation (also called dose ramping or dose titration) protocols are widely used in preclinical infusion studies for dose-response characterization, maximum tolerated dose (MTD) determination, and to allow gradual physiological adaptation to a drug's pharmacological effects. In a within-subject escalating dose design, a single animal receives progressively increasing infusion rates over sequential time intervals, with each step maintained long enough to approach or reach pharmacokinetic steady state before escalating to the next level. This design is statistically efficient because each animal serves as its own control, reducing inter-animal variability and the total number of animals required. Common escalation schemes include linear step increments (e.g., 1x, 2x, 3x, 4x the base rate), logarithmic increments (e.g., 0.1, 0.3, 1, 3, 10 mg/kg/hr), or modified Fibonacci sequences. The duration of each step depends on the drug's pharmacokinetic profile: for a drug with a 30-minute half-life, each step should last at least 2-2.5 hours (approximately 4-5 half-lives) to reach steady state, though shorter intervals of 15-30 minutes may be acceptable for acute pharmacodynamic assessments. Critical considerations include cumulative drug exposure (earlier doses contribute to plasma levels at later steps), potential for receptor desensitization or sensitization, and the need to maintain total infusion volume within blood volume safety limits even at the highest dose step. The syringe concentration is fixed, so escalation is achieved solely by increasing the pump flow rate, and the maximum dose is constrained by either the pump's maximum flow rate or the blood volume limit, whichever is reached first.

Frequently asked

How do I convert a mg/kg/hr dose to a pump flow rate in uL/min?
To convert a weight-normalized dose rate (mg/kg/hr) to a volumetric pump flow rate (uL/min), you need three values: the dose rate, the animal body weight, and the drug concentration in solution. The formula is: Flow Rate (uL/min) = [Dose (mg/kg/hr) x Body Weight (kg)] / [Concentration (mg/mL) x 60 min/hr] x 1000 uL/mL. For example, delivering 10 mg/kg/hr to a 0.025 kg mouse using a 5 mg/mL solution requires (10 x 0.025) / (5 x 60) x 1000 = 0.833 uL/min. This calculator performs this conversion automatically and accounts for unit conversions between common dose rate and concentration units.
What are the blood volume limits for continuous IV infusion in rodents?
Published guidelines from the European Medicines Agency and institutional animal care committees establish maximum infusion volume limits based on total blood volume. Mice have an estimated blood volume of approximately 72 mL/kg (about 1.8 mL for a 25 g mouse), while rats have approximately 64 mL/kg (about 16 mL for a 250 g rat). For continuous IV infusion, the generally accepted maximum rate is 4 mL/kg/hr for conscious rodents and up to 10 mL/kg/hr for anesthetized animals over short durations. Exceeding these limits risks hemodilution, cardiovascular overload, and pulmonary edema. This tool checks your calculated flow rate against published blood volume tables and warns when infusion volumes approach safety thresholds.
How do I plan a dose escalation (ramp) protocol for IV infusion?
Dose escalation or dose-ramp protocols involve incrementally increasing the infusion rate over defined time intervals to establish dose-response relationships or to allow physiological adaptation before reaching the target dose. A typical approach uses 3-5 dose steps, each lasting 15-60 minutes, escalating from a sub-therapeutic dose to the target dose. For example, a three-step ramp might deliver 25%, 50%, and 100% of the target dose, each for 30 minutes. When planning ramps, the drug concentration in the syringe remains fixed, so the pump flow rate must increase at each step. This planner calculates the flow rate for each ramp step and verifies that even the highest step remains within blood volume safety limits.
How do I select the right syringe size for a rodent infusion study?
Syringe selection depends on the total volume needed (flow rate x infusion duration x number of animals + overage) and the required flow rate accuracy. Smaller syringes provide better resolution at low flow rates because the linear displacement per unit volume is greater, reducing the impact of stepper motor step size on flow pulsatility. For mouse studies at uL/min rates, 1 mL or 500 uL syringes are typical. For rat studies at higher flow rates, 5-10 mL syringes may be appropriate. As a rule of thumb, the total infusion volume should not exceed 80% of the syringe capacity to avoid running dry. This tool calculates total required volume including a configurable overage percentage (default 20%) and recommends an appropriate syringe size.
What are common infusion vehicles and their compatibility considerations?
The choice of infusion vehicle affects drug solubility, stability, tonicity, and potential toxicity. Normal saline (0.9% NaCl) is the most common vehicle for IV infusion because it is isotonic and well-tolerated. Other acceptable vehicles include 5% dextrose (D5W), phosphate-buffered saline (PBS), and Ringer's lactate. Organic co-solvents such as DMSO, PEG-400, or ethanol are sometimes required for poorly soluble compounds but must be kept within toxicity limits: DMSO should not exceed 1-2% of the final infusion volume for IV delivery, and ethanol should remain below 10%. Cyclodextrins (e.g., sulfobutylether-beta-cyclodextrin) are commonly used to improve aqueous solubility without organic solvents. Always verify vehicle compatibility with your tubing material — DMSO and some organic solvents can swell or degrade silicone and certain polymer tubings.
What are standard infusion protocols for PK studies in mice and rats?
Pharmacokinetic (PK) infusion studies typically use two main protocols: constant-rate infusion to steady state, or loading dose plus maintenance infusion. For constant-rate infusion, the drug is delivered at a fixed rate until plasma concentrations reach steady state, which takes approximately 4-5 elimination half-lives. A loading dose protocol shortens the time to steady state by delivering a bolus (often over 5-10 minutes) calculated as the target steady-state concentration multiplied by the volume of distribution, followed immediately by the maintenance infusion rate. Common infusion durations in rodent PK studies range from 1 hour for acute exposure assessments to 24-72 hours for steady-state PK profiling. Jugular vein catheterization is the standard vascular access route, though tail vein infusion is used for shorter-duration studies in mice.
325
Free tools
1,200+
Institutions
100%
Client-side
0
Uploads required